Citius Pharmaceuticals Inc
Company Profile
Business description
Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. It is currently advancing four proprietary product candidates: LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma . Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory distress syndrome.
Contact
11 Commerce Drive
First Floor
Cranford NJ 07016
USAT: +1 908 967-6677
E: info@citiuspharma.com
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
30 September 2024
Employees
22
Stocks News & Analysis
stocks
3 shares with high dividend yields from our Global Best Ideas list
video
Our view of mining shares
stocks
Undervalued ASX share with robust cash flow
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 8,208.60 | 42.20 | 0.52% |
| CAC 40 | 7,622.02 | 87.50 | 1.16% |
| DAX 40 | 18,407.07 | 235.14 | 1.29% |
| Dow JONES (US) | 40,415.44 | 127.91 | 0.32% |
| FTSE 100 | 8,196.28 | 2.50 | -0.03% |
| HKSE | 17,487.34 | 148.54 | -0.84% |
| NASDAQ | 18,007.57 | 280.63 | 1.58% |
| Nikkei 225 | 39,594.39 | 4.61 | -0.01% |
| NZX 50 Index | 12,425.58 | 115.67 | 0.94% |
| S&P 500 | 5,564.41 | 59.41 | 1.08% |
| S&P/ASX 200 | 7,971.10 | 39.40 | 0.50% |
| SSE Composite Index | 2,916.64 | 47.58 | -1.60% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Alumina Ltd AWC | 1.45 | 0.03 | -1.69% |
| Sayona Mining Ltd SYA | 0.03 | 0.00 | 0.00% |
| Droneshield Ltd DRO | 1.42 | 0.13 | -8.39% |
| Zip Co Ltd ZIP | 1.80 | 0.11 | 6.19% |
| Core Lithium Ltd CXO | 0.10 | 0.00 | -2.00% |
| South32 Ltd S32 | 2.98 | 0.01 | -0.33% |
| Spartan Resources Ltd SPR | 1.23 | 0.24 | 23.62% |
| Pilbara Minerals Ltd PLS | 2.89 | 0.00 | 0.00% |
| Imugene Ltd IMU | 0.06 | 0.00 | 7.14% |
| Mesoblast Ltd MSB | 1.31 | 0.15 | 12.99% |